📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-12 16:05
138 analysed today
FollowTelegram
138
Today
150,089
All-time analysed
43,015
Positive
6,671
Negative
91,681
Neutral
8,654
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
7 announcements match the current filters (relevance ≥ 5).
National Oxygen Q1 Revenue Drops 60% YoY to ₹3.04 Cr; Net Loss Widens to ₹2.22 Cr
National Oxygen reported a weak Q1 FY27 with revenue falling 59.8% YoY to ₹3.04 Cr, primarily driven by the closure of its Pondicherry LOX plant in April 2026. Net loss widened to ₹2.22 Cr from a loss of ₹1.87 Cr in the same period last year. The company is facing severe financial stress with a negative net worth of ₹-6 Cr and debt of ₹29 Cr, which equals its entire market capitalization. Management cited severe competition and high operating costs, particularly power and maintenance, as reasons for the plant shutdown.
Confidence: HIGH
What changedThe company has significantly downsized its operations by closing the Pondicherry plant, leading to a sharp contraction in revenue and widening losses.
Why it mattersThe company is in a precarious financial position with negative net worth and high debt; the operational contraction suggests the business is struggling to remain viable in a competitive industrial gas market.
Revenue (Q1 FY27): ₹3.04 CrNet Loss (Q1 FY27): ₹2.22 CrDebt to Market Cap: 1.0xNet Worth: ₹-6 CrRevenue vs TTM Revenue: 13.2%
📅 Short termThe stock is likely to face downward pressure as the market reacts to the 60% revenue drop and the formalization of the plant closure.
📈 Long termThe long-term outlook is highly uncertain given the negative net worth and the structural decline in the company's manufacturing footprint.
⚠ Risk flags
- Negative net worth
- High debt relative to revenue
- Operational contraction (plant closure)
- Severe competition in the industrial gas segment
Key Highlights
Revenue from operations declined 59.8% YoY to ₹3.04 Cr from ₹7.58 Cr in June 2025.
Net loss for the quarter widened to ₹2.22 Cr compared to a loss of ₹1.87 Cr in the previous year's corresponding quarter.
The Pondicherry LOX plant operations were officially stopped effective April 6, 2026, due to high costs and competition.
Finance costs stood at ₹0.45 Cr, representing nearly 15% of the total quarterly revenue.
Earnings Per Share (EPS) for the quarter was negative ₹4.38, worsening from negative ₹3.71 YoY.
👀 What to Watch
Investors should monitor the company's ability to service its ₹29 Cr debt given the shrinking revenue base and negative net worth. Watch for any management commentary regarding the potential sale of assets or capital infusion to stabilize the balance sheet.
National Oxygen Q1 FY27: Net Loss Widens to ₹2.22 Cr; Revenue Drops 60% YoY
National Oxygen Limited reported a weak performance for the quarter ended June 30, 2026, with revenue from operations falling 59.8% YoY to ₹3.05 Cr. The company posted a net loss of ₹2.22 Cr, widening from a loss of ₹1.87 Cr in the same period last year. A major operational shift occurred as the company halted its Pondicherry LOX plant operations on April 6, 2026, due to high power costs and competition. The company continues to operate with a negative net worth of ₹-6 Cr and high debt levels relative to its ₹29 Cr market capitalization.
Confidence: HIGH
What changedThe company has transitioned to a smaller operational footprint following the closure of its Pondicherry LOX plant in April 2026, leading to a significant drop in quarterly revenue.
Why it mattersThe sharp revenue contraction and continued losses exacerbate the company's financial distress, characterized by a negative net worth and high debt-to-equity ratio.
Revenue (Q1 FY27): ₹3.05 CrNet Loss (Q1 FY27): ₹2.22 CrRevenue vs TTM Revenue: 13.26%YoY Revenue Growth: -59.8%Debt: ₹29 Cr
📅 Short termNegative sentiment is likely as the market reacts to the 60% revenue drop and the formalization of the plant closure.
📈 Long termThe long-term outlook remains highly challenging due to negative net worth and the loss of a major production facility, suggesting limited recovery potential without significant restructuring.
⚠ Risk flags
- Negative net worth of ₹-6 Cr
- High debt of ₹29 Cr relative to market cap
- Operational shutdown of Pondicherry plant
- Consistent quarterly losses
Key Highlights
Revenue from operations declined sharply to ₹3.05 Cr from ₹7.58 Cr in the year-ago quarter.
Net loss for the quarter widened to ₹2.22 Cr, resulting in a negative EPS of ₹4.38.
Pondicherry LOX plant operations were permanently stopped effective April 6, 2026, to curb operating losses.
Total expenses of ₹5.29 Cr significantly exceeded total income of ₹3.08 Cr for the quarter.
Power and fuel costs remained a major burden at ₹0.91 Cr, despite the plant closure.
👀 What to Watch
Investors should monitor the company's ability to service its ₹29 Cr debt given the shrinking revenue base and negative net worth. The impact of the Pondicherry plant closure on long-term fixed cost reduction is the key metric to watch in upcoming quarters.
National Oxygen to Seek Shareholder Approval for Sale of Perundurai Unit Assets
National Oxygen Ltd has issued its FY2025-26 Annual Report, scheduling its 51st AGM for August 28, 2026. The key agenda item is a special resolution to sell, transfer, or dispose of assets at the SIPCOT-Perundurai unit under Section 180(1)(a). This comes as the company faces significant financial stress, including a negative net worth of Rs -6 Cr and a total debt of Rs 29 Cr. Revenue for FY26 stood at Rs 22.96 Cr, a sharp decline from Rs 40.58 Cr in FY25.
Confidence: HIGH
What changedThe company is formally seeking shareholder permission to exit or sell down its Perundurai manufacturing facility, one of its three primary factory locations.
Why it mattersFor a micro-cap company with negative net worth and declining revenues, the sale of a major unit is a critical deleveraging or survival move that will structurally alter its production capacity and balance sheet.
FY26 Revenue: Rs 22.96 CrTotal Debt: Rs 29 CrNet Worth: Rs -6 CrDebt to Market Cap: 0.93AGM Date: 28th August 2026
📅 Short termThe stock may remain volatile as the market assesses the implications of the asset sale and the potential for debt repayment.
📈 Long termThe company's long-term viability depends on successful deleveraging and stabilizing its industrial gas operations after the proposed asset disposal.
⚠ Risk flags
- Negative net worth
- High debt levels
- Declining revenue trend
- Promoter stake reduction
Key Highlights
Proposed sale or disposal of assets at the SIPCOT - Perundurai unit as a whole undertaking.
FY26 revenue declined significantly to Rs 22.96 Cr from Rs 40.58 Cr in the previous year.
Company reports a negative net worth of Rs -6 Cr against a total debt of Rs 29 Cr.
Promoter holding has decreased from 71.24% in September 2025 to 65.55% in June 2026.
AGM scheduled for August 28, 2026, with e-voting starting from August 25, 2026.
👀 What to Watch
Investors should monitor the outcome of the AGM resolution regarding the Perundurai unit sale and watch for subsequent disclosures on the sale consideration and its impact on debt reduction.
National Oxygen to Sell Assets at Perundurai and Pondicherry Units; 51st AGM on Aug 28
National Oxygen's board has approved the sale or disposal of assets at its Perundurai unit and plant/machinery at its Pondicherry unit, pending shareholder approval at the August 28, 2026 AGM. This move is critical as the company faces severe financial stress, including a negative net worth of Rs -6 Cr and debt of Rs 29 Cr, which equals its entire market capitalization. The board also approved adopting a new MOA and AOA to align with the Companies Act, 2013. Investors should monitor the sale proceeds as they will be vital for addressing the company's leverage.
Confidence: HIGH
What changedThe company has initiated a formal process to sell off manufacturing assets at two of its locations, moving away from its current operational structure.
Why it mattersWith debt equal to its market cap and negative net worth, these asset sales are likely a necessary deleveraging move, though they may significantly reduce the company's future production capacity and revenue potential.
Debt to Market Cap: 100% (Rs 29 Cr / Rs 29 Cr)Net Worth: Rs -6 CrTTM Revenue: Rs 23 CrAGM Date: August 28, 2026
📅 Short termThe stock may see volatility as the market reacts to the potential downsizing and waits for specific financial details of the asset disposals.
📈 Long termThe company is undergoing a major structural contraction; while this may stabilize the balance sheet, it indicates a shrinking business footprint.
⚠ Risk flags
- Significant reduction in operating assets
- Negative net worth
- High debt-to-equity ratio
- Execution risk of asset sales
Key Highlights
Board approved the sale/transfer/disposal of assets at the SIPCOT - Perundurai unit.
Board approved the sale of Plant and Machinery (Liquid Unit) at the Pondicherry unit.
51st Annual General Meeting (AGM) scheduled for August 28, 2026, via video conference.
Book closure period for the AGM set from August 22 to August 28, 2026.
Company currently operates with a negative net worth of Rs -6 Cr and TTM revenue of Rs 23 Cr.
👀 What to Watch
Monitor the outcome of the August 28 AGM for shareholder approval and subsequent disclosures regarding the valuation of the assets being sold and the plan for debt repayment.
National Oxygen to Sell Assets at Perundurai and Pondicherry Units; AGM Set for Aug 28
National Oxygen's board has approved the sale, transfer, or disposal of assets at its SIPCOT-Perundurai unit and the plant and machinery at its Pondicherry unit. These disposals are subject to shareholder approval at the upcoming 51st AGM on August 28, 2026. The move comes as the company faces significant financial stress, including a negative net worth of ₹6 Cr and a debt of ₹29 Cr against a market cap of ₹29 Cr. Specific transaction values for the asset sales were not disclosed in this preliminary filing.
Confidence: MEDIUM
What changedThe company has transitioned from operating its Perundurai and Pondicherry units to seeking formal approval for their disposal.
Why it mattersFor a micro-cap company with negative net worth and declining revenues (₹23 Cr TTM vs ₹40.58 Cr FY25), selling core assets is a major restructuring event that could either stabilize the balance sheet or significantly reduce future earning capacity.
Debt to Market Cap: 100%Net Worth: ₹-6 CrTTM Revenue: ₹23 CrAGM Date: 28-Aug-2026Promoter Holding (Jun 2026): 65.55%
📅 Short termThe stock may remain volatile as the market digests the potential downsizing of operations and awaits specific sale considerations.
📈 Long termThe company is undergoing a structural contraction; the long-term viability depends on the remaining assets' ability to generate positive OPM, which was -14.4% in the TTM period.
⚠ Risk flags
- Negative net worth
- High debt levels
- Asset disposal may lead to significant revenue loss
- Declining promoter holding trend
Key Highlights
Board approved the sale/disposal of assets as a whole at the SIPCOT - Perundurai unit.
Board approved the sale/disposal of Plant and Machinery (Liquid Unit) at the Pondicherry unit.
51st Annual General Meeting (AGM) scheduled for August 28, 2026, via video conference.
Book closure period for the AGM set from August 22 to August 28, 2026.
Company reported a negative net worth of ₹-6 Cr and total debt of ₹29 Cr in recent financials.
👀 What to Watch
Investors should closely monitor the detailed disclosure post-shareholder approval to understand the valuation of these assets and whether proceeds will be used to deleverage the ₹29 Cr debt.
Rs 8.91 Cr Preferential Issue Withdrawn by National Oxygen Ltd Due to Stock Price Decline
National Oxygen Ltd has officially withdrawn its proposal to raise capital through a preferential issue of 9,50,000 equity shares to a promoter group entity, Saraf Housing Development Private Limited. The issue was originally priced at Rs 93.80 per share, but the company's stock has since declined significantly to approximately Rs 58.1. The promoter expressed reservations about the previously approved price, leading the Board to cancel the fundraise and withdraw its application from BSE.
Confidence: HIGH
What changedThe company has terminated a planned Rs 8.91 crore equity infusion from its promoter group that was initiated in April 2026.
Why it mattersThe withdrawal indicates that the promoter is unwilling to infuse capital at the previously agreed premium given the 58.4% decline in stock price over the last 12 months, potentially delaying business plans that required this funding.
Proposed Shares: 9,50,000Issue Price: Rs 93.80Current Market Price: Rs 58.1Aggregate Value (Calculated): Rs 8,91,10,00012-Month Price Return: -58.4%
📅 Short termNegative sentiment is expected as the market reacts to the loss of a confirmed capital injection and the promoter's reluctance to invest at the prior valuation.
📈 Long termThe company may need to re-evaluate its capital structure or wait for a price recovery to attract investment, which could slow down long-term growth or debt reduction efforts.
⚠ Risk flags
- Funding risk
- Promoter reservation
- High stock price volatility
Key Highlights
Cancellation of 9,50,000 equity shares proposed for allotment to the promoter group.
Original issue price of Rs 93.80 is significantly higher than the current market price of Rs 58.1.
Total planned fundraise of Rs 8,91,10,000 (as per share count and price) has been scrapped.
The proposal was previously approved by shareholders in an EGM held on May 28, 2026.
Company cited 'prevailing market conditions' and 'significant decline in market price' as the primary reasons for withdrawal.
👀 What to Watch
Monitor for any fresh fund-raising announcements at revised (lower) valuations and observe if the company faces liquidity constraints due to the cancelled capital infusion.
National Oxygen Ltd Withdraws Rs 8.91 Cr Preferential Issue Due to Share Price Decline
National Oxygen Ltd has officially withdrawn its proposed preferential issue of 9,50,000 equity shares to a promoter group entity, Saraf Housing Development Private Limited. The issue was originally approved at a price of Rs 93.80 per share in May 2026, but the company's market price has since fallen significantly to approximately Rs 58.1. Due to this price gap, the promoter-investor expressed reservations, leading the Board to cancel the fundraise. The company stated it may consider a fresh fund-raising exercise at a later date depending on market conditions.
Confidence: HIGH
What changedThe company has cancelled a previously approved capital infusion from promoters because the agreed-upon price (Rs 93.80) became unviable following a sharp drop in the market price.
Why it mattersThe failure to complete this fundraise suggests the company will not receive the planned Rs 8.91 cr in the immediate term, potentially delaying business plans or debt servicing, and reflects poor market confidence in the stock's valuation.
Proposed Issue Price: Rs 93.80Current Market Price: Rs 58.1Total Issue Size: Rs 8.91 crNumber of Shares: 9,50,00012-Month Price Return: -58.4%
📅 Short termThe stock may face continued pressure as the market reacts to the promoter's reluctance to infuse capital at the previously agreed premium.
📈 Long termStructural concerns remain regarding the company's ability to raise capital without significant dilution if the share price does not recover.
⚠ Risk flags
- Capital raising failure
- Promoter hesitation at previous valuations
- Significant equity price erosion
- Potential liquidity constraints
Key Highlights
Cancellation of 9,50,000 equity shares intended for issuance to the promoter group.
Proposed issue price of Rs 93.80 was at a significant premium to the current market price of Rs 58.1.
Total planned fundraise of Rs 8,91,10,000 (Rs 8.91 cr) has been scrapped.
The withdrawal follows a 58.4% decline in share price over the last 12 months.
Application for in-principle approval previously submitted to BSE is being withdrawn.
👀 What to Watch
Investors should monitor the company's cash flow requirements and watch for a potential fresh fundraise at a lower valuation, which would result in higher equity dilution.
